Ironwood Investment Management LLC Checkpoint Therapeutics, Inc. Transaction History

Ironwood Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.02 - $10.6 $115 - $1,197	-113 Reduced 0.08%	138,903 $144,000
Q2 2022 Aug 12, 2022	BUY	$0.97 - $1.77 $102 - $187	106 Added 0.08%	139,016 $143,000
Q1 2022 May 10, 2022	BUY	$1.53 - $3.25 $4,215 - $8,953	2,755 Added 2.02%	138,910 $246,000
Q4 2021 Feb 10, 2022	BUY	$2.68 - $4.46 $11,478 - $19,102	4,283 Added 3.25%	136,155 $423,000
Q3 2021 Nov 12, 2021	BUY	$2.5 - $3.53 $807 - $1,140	323 Added 0.25%	131,872 $435,000
Q2 2021 Aug 16, 2021	SELL	$2.36 - $3.2 $6,230 - $8,448	-2,640 Reduced 1.97%	131,549 $388,000
Q1 2021 May 14, 2021	BUY	$2.6 - $4.16 $46,186 - $73,898	17,764 Added 15.26%	134,189 $421,000
Q4 2020 Feb 12, 2021	SELL	$2.19 - $2.96 $42,967 - $58,075	-19,620 Reduced 14.42%	116,425 $309,000
Q3 2020 Nov 13, 2020	BUY	$1.62 - $4.24 $220,392 - $576,830	136,045 New	136,045 $365,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $351M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Ironwood Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ironwood Investment Management LLC with notifications on news.